Kristina Althoff

Mutational dynamics between primary and relapse neuroblastomas

Alexander Schramm, Johannes Köster, Yassen Assenov et al. · Nature Genetics · 2015 · 319 citations

Medicine, Molecular Genetics, Oncology +13

Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition

Anton G. Henssen, Kristina Althoff, Andrea Odersky et al. · Clinical Cancer Research · 2015 · 180 citations · Full text

Medicine, Cancer Biology, Oncology +12

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies

Kristina Althoff, Anneleen Beckers, Emma Bell et al. · Oncogene · 2014 · 147 citations · Full text

Medicine, Genetics, Oncology +15

BET bromodomain protein inhibition is a therapeutic option for medulloblastoma

Anton G. Henssen, Theresa Thor, Andrea Odersky et al. · Oncotarget · 2013 · 142 citations · Full text

Medicine, Oncology, Pharmacology +16

Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression

Julian Philipp Layer, Marie T. Kronmüller, Thomas Quast et al. · OncoImmunology · 2017 · 142 citations · Full text

Life Sciences, Immunology, Oncology +15